Clincosm LogoSign in Get a demo

uveal melanoma

Showing 1 - 25 of 81
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Phase of Uveal Melanoma: A Prospective Multi-method Study

Not yet recruiting
  • Uveal Melanoma
  • Questionnaires and interviews
  • (no location specified)
Oct 4, 2023

Psychoeducation for Uveal Melanoma

Not yet recruiting
  • Uveal Melanoma
  • Education for Intervention
  • Best Practice
  • (no location specified)
Oct 4, 2023

Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

Not yet recruiting
  • Uveal Melanoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Oct 5, 2023

Choroidal Melanoma, Indeterminate Lesions, Uveal Melanoma Trial in United States (Belzupacap Sarotalocan, Suprachoroidal

Recruiting
  • Choroidal Melanoma
  • +3 more
  • Belzupacap Sarotalocan
  • +5 more
  • Birmingham, Alabama
  • +32 more
Aug 23, 2023

Uveal Melanoma Trial in Grand Rapids (Darovasertib)

Recruiting
  • Uveal Melanoma
  • Grand Rapids, Michigan
    The Cancer and Hematology Centers
Jun 14, 2023

Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

Not yet recruiting
  • Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Jun 5, 2023

Uveal Melanoma Trial in Ribeirão Preto (Melphalan Injection, Plaque brachytherapy)

Enrolling by invitation
  • Uveal Melanoma
  • Melphalan Injection
  • Plaque brachytherapy
  • Ribeirão Preto, SP, Brazil
    Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto
May 29, 2023

Morphological, Genetic and Tumour Microenvironment

Recruiting
  • Uveal Melanoma
  • cytogenetic analysis on tumour tissue
  • Digital Pathology
  • Rome, Italy
    Monica Maria Pagliara - Oncologia Oculare
May 26, 2023

Uveal Melanoma Trial in Vienna (any therapy suitable)

Recruiting
  • Uveal Melanoma
  • any therapy suitable
  • Vienna, Austria
    Medical University of Vienna
Feb 8, 2023

Breast Cancer, Colorectal Cancer, Uveal Melanoma Trial in Orlando, Pittsburgh (TBio-4101, Pembrolizumab)

Recruiting
  • Breast Cancer
  • +2 more
  • Orlando, Florida
  • +1 more
Feb 1, 2023

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Uveal Melanoma Trial in Nice, Paris (Supportive care visit with questionnaires, Oncological standard visit)

Recruiting
  • Uveal Melanoma
  • Supportive care visit with questionnaires
  • Oncological standard visit
  • Nice, France
  • +1 more
Jan 19, 2023

Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

Completed
  • Mesothelioma
  • +3 more
  • Gainesville, Florida
  • +2 more
Jan 4, 2023

Uveal Melanoma Trial in San Francisco (stereotactic body radiotherapy, Immunotherapy)

Recruiting
  • Uveal Melanoma
  • San Francisco, California
    California Pacific Medical Center Research Institute
Dec 2, 2022

Uveal Melanoma Trial in Germany (Autologous Dendritic Cells loaded with autologous Tumor RNA)

Active, not recruiting
  • Uveal Melanoma
  • Autologous Dendritic Cells loaded with autologous Tumor RNA
  • Erlangen, Bayern, Germany
  • +7 more
Nov 29, 2022

Uveal Melanoma Trial in Minneapolis (PAC-1, Entrectinib)

Active, not recruiting
  • Uveal Melanoma
  • Minneapolis, Minnesota
    HealthPartners Institute Regions Cancer Care Center
Nov 15, 2022

Uveal Melanoma, Melanoma, Metastatic Uveal Melanoma Trial in Harrison, New York (Lifileucel (LN-144))

Recruiting
  • Uveal Melanoma
  • +3 more
  • Lifileucel (LN-144)
  • Harrison, New York
  • +1 more
Nov 8, 2022

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Cutaneous Melanoma, Uveal Melanoma, Mucosal Melanoma Trial in Worldwide (RO7293583, Tocilizumab, Obinutuzumab)

Completed
  • Cutaneous Melanoma
  • +2 more
  • Boston, Massachusetts
  • +13 more
Sep 30, 2022

Uveal Melanoma Trial in Worldwide (LXS196, LXS196 and HDM201)

Terminated
  • Uveal Melanoma
  • New York, New York
  • +5 more
Sep 27, 2022

Uveal Melanoma Trial in Spain (Tislelizumab, Sitravatinib Malate)

Not yet recruiting
  • Uveal Melanoma
  • Málaga, Andalucia, Spain
  • +5 more
Sep 13, 2022

Uveal Melanoma, Uveal Melanoma, Posterior, Medium/Large Size, Eye Cancer, Intraocular Melanoma Trial in Stockholm (Melatonin)

Not yet recruiting
  • Uveal Melanoma
  • +2 more
  • Stockholm, Sweden
    St. Erik Eye Hospital
Aug 14, 2022

Uveal Melanoma, Metastatic Trial in Tampa (4.7 microCi 225Ac-MTI-201, 9.5 microCi of 225Ac-MTI-201, 19 microCi of 225Ac-MTI-201)

Recruiting
  • Uveal Melanoma
  • Metastatic
  • 4.7 microCi 225Ac-MTI-201
  • +11 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 9, 2022

Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

Not yet recruiting
  • Recurrent Metastatic Melanoma
  • +3 more
  • Boston, Massachusetts
  • +1 more
Jul 29, 2022

Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • Scottsdale, Arizona
  • +4 more
Jul 20, 2022